Figure 1From: Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsules Tolerability reported by respondents switched to tablets BID or QD. Back to article page